Pinned Tweet
New primer with @tamaranopper analyzes health and wellness benefits in the US, arguing that decades of pervasive yet blind support for these benefits has resulted in a complex and privatized approach to public health we call wellness capitalism, datasociety.net/library/well…
Eve Zel retweeted
Sue Zelickson, matriarch of the Twin Cities food scene, dies at 91 startribune.com/sue-zelickso…
Eve Zel retweeted
Sue Zelickson, long time food reporter, WCCO Radio host, philanthropist, and community pillar in the Twin Cities culinary scene has died at 91. She spent over 50 years connecting chefs, empowering women, and raising money for charitable organizations.
audacy.com/wccoradio/news/lo…
Eve Zel retweeted
Gr8 post. “If there has been this great disavowal, where is the evidence? How have the casebooks changed, how has legal education changed? And where are the renunciations of Coase, Posner, and other canonical works, by a new generation of L&E scholars?” lpeproject.org/blog/two-dogm…
Today, Andrew Miller explains how consumer profiling creates new patterns of advantage and disadvantage in the market. But because these practices are often invisible to consumers, those on the losing end can't organize against them.
lpeproject.org/blog/coalitio…
During the early years of the AIDS crisis, government policies effectively excluded women.
Today @LPEblog, @veenadubal interviews @AzizaAhmed on how feminist activists forced recognition of the epidemic’s reach.
Plus, I had no idea Posner was so obsessed with sex.
Eve Zel retweeted
In 2015, Martin Shkreli became the most hated man in America by raising the price of Daraprim – an antiparasitic essential for immunocompromised patients – from $17.50 to $750 per pill.
How much does Daraprim cost today? $750 per pill.
Eve Zel retweeted
I will simply never recover from reading this sentence:
"Since Georgia implemented work requirements in 2020, they have spent twice as much on Deloitte consultants and administrative costs as on healthcare for people."
!! :)
Four recent and upcoming NYU Law grads have been named as Skadden Fellows. Congrats to Vedan Anthony-North ’21, Joelle Besch ’26, Danielle Miles-Langaigne ’26, and Eve Zelickson ’26 for receiving one of the nation’s most prestigious public interest law fellowships! ow.ly/zsEH50XKsAG
Fascinating interview with @benchansfield about the wave of landlord-perpetrated arson in the 1970s. lpeproject.org/blog/the-busi…
Eve Zel retweeted
"The benefit was designed not to maintain a healthy market for hospice, but to disentangle hospice from market logic. To achieve this, we need to do more than stabilize the hospice industry through greater competition—we need to create spaces where care remains uncommodified."
Eve Zel retweeted
I love New York and I’m sorry for all the stuff I said when the G train was delayed
Eve Zel retweeted
In the article published in the @LPEBlog on 29 July 2025, @akapczynski, John Thomas Smith Professor of Law at Yale Law School and a cofounder of the LPE, examines the structural obstacles that hinder the widespread availability of affordable medicines.
Eve Zel retweeted
Today, @akapczynski explains how recent public initiatives to manufacture insulin highlight both the promise and pitfalls of the new politics of “abundance.”
lpeproject.org/blog/what-sta…
Today on @LPEblog, @cmorten2 on why it's difficult to measure "value" in health care, and how companies manipulate and distort the informational environments around their products.
lpeproject.org/blog/whats-va…
Eve Zel retweeted
Grateful to join this Law & Political Economy series on corporate power in health care.
I delve into the ideology behind “value-based payment”—its roots in managed care, neoliberalism, & a flawed theory of health care regulation decades in the making.
Eve Zel retweeted
Today, @Hayrook explains why “value-based payment," though often heralded as a policy innovation, is best understood as a continuation of the neoliberal effort to outsource public regulation to the private sector.
lpeproject.org/blog/the-same…
Eve Zel retweeted
Today, Fumika Mizuno explains how two powerful corporations came to control over 70% of the outpatient dialysis market — a case study in how public funding can entrench private power in health care.
lpeproject.org/blog/a-dialys…
New essay on how the government helped entrench the DaVita and Fresenius duopoly, by Fumika Mizuno at @LPEblog lpeproject.org/blog/a-dialys…

















